Peripheral neurotensin participates in the modulation of pre- and postprandial intestinal motility in rats.
The present study was undertaken to determine whether neurotensin is involved in the regulation of the intestinal postprandial motor response and, if so, whether the regulatory pathway depends upon peripheral or central neurotensin secretion. Neurotensin, injected by the i.v. route (5 micrograms/kg) during the fasting state, induced firstly an increased irregular spiking activity during 30-40 min. This effect was followed by an increase of frequency of the myoelectrical complexes during 60 min. When injected by the i.c.v. route, neurotensin (0.5 microgram/kg) reinforced the fasting motility pattern of the small intestine after a latency of 70 min. Neurotensin was ineffective on the colon. The neurotensin receptor antagonist SR 48692 (200 micrograms/kg i.v.) reduced the duration of the postprandial motor response of the small intestine and blocked the late postprandial phase on the proximal colon while it suppressed the early postprandial phase on the distal colon. When administered i.c.v. (20 micrograms/kg), SR 48692 had no effect. It is concluded that neurotensin modulates intestinal postprandial motility essentially by a peripheral regulatory pathway. Endogenous neurotensin is involved in the maintenance of the postprandial motility pattern on the small intestine and the proximal colon while it is involved in the initiation of this response on the distal colon. This suggests that endogenous neurotensin acts via both endocrine and nervous mechanisms.
Pellissier
S
S
Laboratory of Applied Physiology and Pharmacology, University of Savoie, Le Bourget du Lac, France.
Eribon
O
O
Chabert
J
J
Gully
D
D
Roche
M
M
D000818:Animals; D003106:Colon / Q000187:drug effects / Q000294:innervation / Q000502:physiology; D004386:Duodenum / Q000187:drug effects / Q000294:innervation / Q000502:physiology; D004435:Eating / Q000502:physiology*; D005215:Fasting / Q000502:physiology*; D005769:Gastrointestinal Motility / Q000187:drug effects / Q000502:physiology*; D007082:Ileum / Q000187:drug effects / Q000294:innervation / Q000502:physiology; D007275:Injections, Intravenous; D008297:Male; D016065:Myoelectric Complex, Migrating / Q000187:drug effects; D009496:Neurotensin / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D017933:Peripheral Nervous System / Q000187:drug effects / Q000502:physiology; D011720:Pyrazoles / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
D011720:Pyrazoles; D011804:Quinolines; C079087:SR 48692; D009496:Neurotensin